JPMorgan Chase & Co. Reiterates “Overweight” Rating for Smith & Nephew (LON:SN)

Smith & Nephew (LON:SN)‘s stock had its “overweight” rating reissued by investment analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Friday, MarketBeat reports.

Other research analysts have also recently issued research reports about the stock. Citigroup lifted their price target on shares of Smith & Nephew from GBX 1,450 to GBX 1,600 and gave the stock a “buy” rating in a research note on Friday, October 31st. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the company a “hold” rating in a report on Wednesday, August 6th. Berenberg Bank upped their target price on shares of Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the stock a “hold” rating in a report on Thursday, August 7th. Finally, Royal Bank Of Canada increased their price objective on shares of Smith & Nephew from GBX 1,400 to GBX 1,700 and gave the company an “outperform” rating in a report on Monday, October 20th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Smith & Nephew presently has a consensus rating of “Moderate Buy” and an average price target of GBX 1,487.60.

Smith & Nephew Stock Performance

SN stock opened at GBX 1,266.50 on Friday. The firm has a fifty day moving average price of GBX 1,365.36 and a 200-day moving average price of GBX 1,221.70. The company has a market capitalization of £13.88 billion, a P/E ratio of 45.60, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51.

Insiders Place Their Bets

In related news, insider Angie Risley bought 373 shares of the stock in a transaction dated Friday, August 22nd. The stock was purchased at an average cost of GBX 1,382 per share, with a total value of £5,154.86. Also, insider Jeremy (Jez) Maiden bought 353 shares of the company’s stock in a transaction on Friday, August 22nd. The stock was bought at an average price of GBX 1,378 per share, for a total transaction of £4,864.34. Insiders have purchased 4,811 shares of company stock valued at $12,947,701 over the last quarter. Corporate insiders own 0.19% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.